AstraZeneca has also reached an agreement with the U.S. Department of Commerce to delay Section 232 tariffs for three years, ...

Bristol Myers Squibb has agreed to acquire Orbital Therapeutics, a privately held biotechnology company pioneering a new ...

Global Supply Chain Centers connect innovation with infrastructure, providing an integrated platform that safeguards advanced ...

Aims to design a vaccine capable of inducing an immune response with bactericidal activity against Pseudomonas aeruginosa.

Aims to address formulation, drug persistence, and delivery challenges by enabling sustained release and enhanced solubility.

Expedition Therapeutics has closed a $165 million Series A financing round to support development of its lead candidate, EXPD ...

Navidea Biopharmaceuticals Inc. has filed for Chapter 11 bankruptcy under Subchapter V in the U.S. Bankruptcy Court for the ...

Mission Bio, a precision medicine company, has appointed Zivjena Vucetic, M.D., Ph.D., as Chief Medical Officer.

The groninger Group, an international manufacturer of filling and closing machines for the pharmaceutical, consumer ...

Paul Josephs, Lifecore Biomedical’s president and chief executive officer, shares insight on the company’s history and ...

Lonza’s new aseptic drug product filling line in Stein (CH) is operationally ready. The filling line was granted a GMP ...

Boehringer Ingelheim has expanded its oncology pipeline with the acquisition of a preclinical small molecule program from ...